Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Am Pharm Assoc (2003) ; 62(3): 734-739, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-34975006

RESUMO

BACKGROUND: Although hospital readmission rates are declining nationally, avoidable readmissions remain a public health concern. Effective readmission interventions are multifaceted and include discharge planning and transition-of-care coordination. Clinical pharmacists are effective contributors to these processes, bringing expertise to discharge counseling, medication reconciliation, medication adherence, and postdischarge follow-up counseling. OBJECTIVE: We evaluated the impact of adding health plan clinical pharmacy management services to an existing discharge program on all-cause readmissions and postdischarge primary physician visits. METHOD: Pharmacy management services by health plan clinical pharmacists of a large regional integrated delivery system were added to an existing optimal discharge planning (ODP) program. Criteria for eligibility for these pharmacists' services included patients who prescribed a new maintenance medication after discharge, received a therapeutic substitution, had a previous discharge within 30 days, or were taking a high-risk medication. A retrospective, observational analysis of a subgroup of patients, who received the pharmacy management services as part of ODP, was performed using a difference-in-difference model, by comparing propensity-matched discharges from February 22, 2016, to January 31, 2017 (preprogram implementation) with discharges from February 22, 2017, to January 31, 2018 (implementation period), to estimate changes in 30-day readmission rates and postdischarge primary physician visits. RESULTS: A total of 111 of the propensity matched received the pharmacy management services; of these, 73% (ODP) versus 64% (non-ODP) were ≥58 years, 60% were females, and 62% (ODP) versus 52% (non-ODP) were Medicare beneficiaries. There was a 16.7% (P = 0.022) statistically significant reduction in combined inpatient and observation 30-day readmissions and a 19.7% increase in 5-day postdischarge follow-up physician visits (P = 0.037) for the subgroup who also received the pharmacy management services. CONCLUSION: Addition of pharmacist management services to an existing hospital discharge program for select at-risk patients was associated with reduced inpatient and observation 30-day readmissions.


Assuntos
Farmacêuticos , Serviço de Farmácia Hospitalar , Assistência ao Convalescente , Idoso , Feminino , Humanos , Masculino , Medicare , Reconciliação de Medicamentos , Alta do Paciente , Readmissão do Paciente , Estudos Retrospectivos , Estados Unidos
2.
Int J Prosthodont ; 34(1): 13-20, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33570515

RESUMO

PURPOSE: To evaluate and compare the occlusal fit of zirconia crowns designed using a digital articulator method and the traditional method in a self-controlled clinical trial. MATERIALS AND METHODS: Two zirconia crowns each were prepared for 12 patients with a single posterior tooth defect using two different methods: a digital articulator method and the traditional method. In the traditional method, casts were scanned using a model scanner, and the relative positions of the maxillary and mandibular arches were determined by the intercuspal occlusion of the casts. In the digital articulator method, casts were mounted on a mechanical articulator and scanned, and the relative positions were determined by their respective positions in the articulator. Additional dynamic occlusal adjustments of the digital articulator crowns were performed. Both groups of zirconia crowns were milled in a five-axis milling machine. The time required for occlusal adjustments, the occlusal contacts, the occlusal contact distributions, the number of occlusal contacts, the relative occlusal forces, and patient satisfaction (visual analog scale score) were evaluated. Wilcoxon test, McNemar test, and paired t test were used to compare the parameters between the two methods. RESULTS: The occlusal adjustment times for the digital articulator and traditional method crowns were 327 ± 226 seconds and 395 ± 338 seconds, respectively (P > .05). There were no significant differences in occlusal contacts, occlusal contact distributions, number of occlusal contacts, relative occlusal forces, or VAS scores between the two methods (P > .05). CONCLUSION: A digital articulator method for single-crown restoration was applied successfully. Crowns fabricated using a digital articulator or the traditional method can achieve acceptable occlusal fit for single-crown restorations.


Assuntos
Articuladores Dentários , Planejamento de Prótese Dentária , Desenho Assistido por Computador , Coroas , Humanos , Zircônio
3.
J Manag Care Spec Pharm ; 27(2): 147-156, 2021 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-33506728

RESUMO

BACKGROUND: Although medication therapy management (MTM) has specific eligibility criteria and is mandated for specific Medicare Part D enrollees, some health plans have expanded MTM eligibility beyond the minimum criteria to include other Medicare Part D enrollees, Medicaid, and commercial health plan patients. Differences exist in the mode of delivery, location of services, type of personnel involved in managing the service, and the subsequent outcomes. The type and intensity of MTM services delivered have evolved with time to more streamlined and robust interventions, necessitating ongoing evaluation of the effect on clinical and economic outcomes. OBJECTIVE: To assess the effect of changes to an existing MTM program on cost of care, utilization, and medication adherence. METHODS: UPMC Health Plan made changes to an existing MTM program by expanding eligibility (customized by the type of health plan), intervention types, pharmacist involvement, and patient followup contacts. After matching our intervention cohort (identified January 2017-June 2018) with the pre-2016 MTM historical controls (patients identified January 2014-June 2015 who would have been eligible if we used the intervention cohort eligibility criteria), we estimated that the effect of the program changes with a difference-in-difference model (preintervention [2014-2016] and postintervention [2017-2019]). Outcomes of interest included cost (total cost of care including medical, pharmacy, and unplanned care [i.e., unscheduled health care use such as emergency department visits] in 2017 U.S. dollars); utilization; medication adherence (proportion of days covered); and return on investment (ROI). Target population included continuously enrolled patients aged ≥ 21 years in the commercial, Medicare, and Medicaid health plans. RESULTS: Total propensity score-matched members was 10,747, 55% of which were in the historic control group. The average (SD) ages after matching the groups were similar (historical control group: 57.08 years [14.23], intervention group: 56.79 years [14.21]) and the majority was female (57%). Comorbidities identified most for patients included hypertension (77%), dyslipidemia (70%), and diabetes (52%). Forty-one percent were in the commercial, 37% in the Medicaid, and 23% in the Medicare health plans. Proportion of care activities undertaken in the intervention period compared with the control period were significantly different: "sent letter to physician" (67% vs. 87%), "sent letter to member" (15% vs. 0%), "pharmacist phone call to physician" (15% vs. 0.1%), and "pharmacist phone call to member" (13% vs. 7%). There were statistically significant reductions in unplanned care across all health plans especially in the Medicare population, in total cost of care, and increases in medication adherence in 4 therapeutic classes: anticoagulants (OR = 1.25, P = 0.005), cardiac medications (OR = 1.20, P < 0.001), statins (OR = 1.21, P < 0.001), and antidepressants (OR = 1.15, P < 0.001). There was a positive ROI of $18.50 per dollar spent, which equated to a cumulative net savings of $11 million over 24 months. CONCLUSIONS: In a large health plan, expanding MTM eligibility, intensifying patient follow-up contact and pharmacist involvement, and improving provider awareness had favorable clinical and economic benefits. DISCLOSURES: There was no funding for this project except employees' time. All authors are employees of UPMC and have no conflicts of interest to report.


Assuntos
Análise Custo-Benefício , Adesão à Medicação/estatística & dados numéricos , Conduta do Tratamento Medicamentoso/organização & administração , Aceitação pelo Paciente de Cuidados de Saúde/estatística & dados numéricos , Regionalização da Saúde/organização & administração , Adulto , Idoso , Comorbidade , Condicionamento Operante , Redução de Custos , Diabetes Mellitus/tratamento farmacológico , Diabetes Mellitus/epidemiologia , Dislipidemias/tratamento farmacológico , Dislipidemias/epidemiologia , Feminino , Humanos , Hipertensão/tratamento farmacológico , Hipertensão/epidemiologia , Masculino , Medicaid/economia , Medicaid/organização & administração , Medicare Part D/economia , Medicare Part D/organização & administração , Conduta do Tratamento Medicamentoso/economia , Pessoa de Meia-Idade , Pennsylvania/epidemiologia , Regionalização da Saúde/economia , Estados Unidos
4.
Am J Prev Med ; 47(4): 403-10, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24951044

RESUMO

BACKGROUND: Workplace wellness programs hold promise for managing the health and costs of the U.S. workforce. These programs have not been rigorously tested in healthcare worksites. PURPOSE: To evaluate the impact of MyHealth on the health and costs of UPMC healthcare workers. DESIGN: Five-year observational study conducted in 2013 with subgroup analyses and propensity-matched pair comparisons to more accurately interpret program effects. SETTING/PARTICIPANTS: UPMC, an integrated health care delivery and financing system headquartered in Pittsburgh, Pennsylvania. Participants included 13,627 UPMC employees who were continuously enrolled in UPMC-sponsored health insurance during the study period and demonstrated participation in MyHealth by completing a Health Risk Assessment in both 2007 and 2011, as well as 4,448 other healthcare workers employed outside of UPMC who did not participate in the program. INTERVENTION: A comprehensive wellness, prevention, and chronic disease management program that ties achievement of health and wellness requirements to receipt of an annual credit on participants' health insurance deductible. MAIN OUTCOME MEASURES: Health-risk levels, medical, pharmacy, and total healthcare costs, and Healthcare Effectiveness Data and Information Set performance rates for prevention and chronic disease management. RESULTS: Significant improvements in health-risk status and increases in use of preventive and chronic disease management services were observed in the intervention group. Although total healthcare costs increased significantly, reductions in costs were significant for those who moved from higher- to the lowest-risk levels. The contrast differences in costs between reduced- and maintained-risk groups was also significant. Matched pair comparisons provided further evidence of program effects on observed reductions in costs and improvements in prevention, but not improvements in chronic disease management. CONCLUSIONS: Incorporating incentivized health management strategies in employer-sponsored health insurance benefit designs can serve as a useful, though not sufficient, tool for managing the health and costs of the U.S. healthcare workforce.


Assuntos
Pessoal de Saúde , Promoção da Saúde/organização & administração , Doenças Profissionais/prevenção & controle , Saúde Ocupacional , Prestação Integrada de Cuidados de Saúde/economia , Prestação Integrada de Cuidados de Saúde/organização & administração , Feminino , Custos de Cuidados de Saúde , Humanos , Seguro Saúde/organização & administração , Masculino , Pessoa de Meia-Idade , Pennsylvania , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA